Brightgene Bio-medical Technology Co. Ltd. Class ASSE: 688166

Report for Q1 2026

Apr 30, 2026 · Issued by Brightgene Bio-medical Technology Co. Ltd. Class A via Shanghai Stock Exchange

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment